Xue Yang
- Pharmaceutical Science top 1%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 9
- Biological Psychiatry top 10%
- Molecular Biology top 5%
- RNA modifications and cancer 9
-
- Nanoplatforms for cancer theranostics 22
-
- Immune cells in cancer 9
-
- Cancer-related Molecular Pathways 6
-
- Photodynamic Therapy Research Studies 6
- Journals
- Oncotarget (5 papers)Frontiers in Bioengineering and Biotechnology (4 papers)Frontiers in Immunology (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xue Yang
146 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmaceutical Science 255
- Cancer Research 614
- Biomaterials 333
- Biological Psychiatry 52
- Molecular Biology 1.3k
Countries citing papers authored by Xue Yang
This map shows the geographic impact of Xue Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Yang more than expected).
Fields of papers citing papers by Xue Yang
This network shows the impact of papers produced by Xue Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Yang. The network helps show where Xue Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 10 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 9 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 19 | |
| 14 | 2023 | 25 | |
| 15 | 2023 | 0 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 158 | |
| 18 | Evaluation of TACE combined with gamma-knife radiotherapy for primary hepatocellular carcinoma | 2012 | 4 |
| 19 | Translators’ Feminist Consciousness and the English Translating of Zang Hua Ci | 2007 | 1 |
| 20 | Dik: The theory of functional grammar | 2000 | 1 |
About Xue Yang
Xue Yang is a scholar working on Cancer Research, Oncology, Biomaterials, Immunology and Molecular Biology, having authored 156 papers that have together received 3.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (22 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Nanoparticle-Based Drug Delivery (9 papers), Immune cells in cancer (9 papers), MicroRNA in disease regulation (8 papers), Cancer-related Molecular Pathways (6 papers) and Photodynamic Therapy Research Studies (6 papers). The work is most often cited by research in Pharmaceutical Science (255 citations), Cancer Research (614 citations), Biomaterials (333 citations), Biological Psychiatry (52 citations) and Molecular Biology (1.3k citations). Xue Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yiqun Yu, Xiaofang Wu, Yibin Fan, Xiaozhou Mou, Xiaoyi Chen, Luo‐Qin Fu, Huipeng Li, Maohua Cai, Minjie Sun and Jing Yu. Their work appears in journals such as Oncotarget, Frontiers in Bioengineering and Biotechnology, Frontiers in Immunology, Oncology Reports and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.